Medicinal Cannabis Taree

There is no fixed list of qualifying conditions. Eligibility rests on a doctor's clinical judgement that medicinal cannabis is appropriate for a patient's specific circumstances, generally where a chronic condition hasn't responded adequately to conventional treatments or where standard treatments cause unacceptable side effects. The prescribing doctor must be satisfied the potential benefit justifies the treatment for that individual patient and must obtain the required regulatory approval before prescribing an unregistered product.

In practice, most prescribing in Australia has involved chronic conditions where other options have been exhausted, and doctors are expected to have tried conventional approaches first. Age matters too, as prescribing to younger patients faces additional scrutiny, and a personal or family history of certain mental health conditions may make treatment unsuitable, since cannabis can worsen some conditions. An assessment appointment is the only way to know whether you're a candidate, as the decision depends entirely on your individual history.

Yes, when prescribed by a doctor through the approved regulatory channels. Medicinal cannabis has been legal in Australia since 2016, accessed through the TGA's Special Access Scheme or from doctors approved as Authorised Prescribers. Products obtained this way are legal to possess and use in NSW in accordance with the prescription, in the same way as other prescription medicines.

The legality has firm boundaries. Cannabis obtained outside the prescription pathway remains illegal, prescribed products cannot legally be shared with anyone else and driving laws are unchanged by a prescription: in NSW it remains an offence to drive with any detectable THC in your system, even with a valid prescription and even when not impaired, and THC can be detected for days after use. CBD-only products don't carry the same driving restriction. Patients considering treatment should factor driving obligations into the decision, and doctors are required to discuss this before prescribing THC-containing products.

CBD (cannabidiol) and THC (tetrahydrocannabinol) are the two main active compounds in medicinal cannabis products, and they behave differently. THC is the psychoactive component, responsible for intoxicating effects, and its medical use is subject to tighter controls, including the NSW driving prohibition. CBD is not intoxicating and does not cause a high, which is why CBD-only products are treated differently under driving laws.

Prescribed products range across a spectrum: CBD-only preparations, THC-dominant products and balanced formulations containing both, available as oils, capsules, sprays and dried flower depending on the approval. Which formulation a doctor selects depends on the condition being treated, the evidence for that use, your sensitivity to side effects and practical considerations such as driving requirements. Side effect profiles differ too, with THC more commonly associated with drowsiness, dizziness and cognitive effects, particularly when starting treatment. Your prescribing doctor explains the specific product recommended and why it suits your circumstances.